Document:

exv10w27

Exhibit 10.27

StemCells

6826 La Valle Plateada

P.O. Box 567

Rancho Santa Fe, CA 92067

619-759-0290

As of February 2, 1998

Ann Tsukamoto, Ph.D.

888 La Mesa Drive Portola

Valley, CA 94028

Dear Ann:

On behalf of StemCells (the “Company”), I am pleased to invite you to join the Company as Senior
Director of Scientific Operations. In this position, you will report to CytoTherapeutics, Inc. Vice
President of Research. However, until such time as this individual is hired, you will report
directly to
me. As Senior Director of Scientific Operations, you will be expected to devote your full business
time, attention and energies to the performance of your duties with the Company. The effective date
of
your employment will be February 2, 1998.

The terms of this offer of employment are as follows:

     1. Compensation. Your Base Salary will be $5,000 biweekly ($130,000 per year) subject to
review and adjustment from time to time. Your salary will begin as of the effective date of
employment. You will also be eligible to participate in the Company’s bonus plan, with a target
bonus of 10% of your base salary.

     2. Benefits. Our benefits program is outlined in the attached summary. Insurance coverage, which will be provided to you as a Company employee, includes life insurance and health and dental coverage. The Company will provide you with $750,000 of term life insurance during the term of your employment.

     During the first year of employment, you will be entitled to three (3) weeks of paid vacation.
Yearly increases in vacation time will be made and accrued according to the Company’s established policies.

     As you know, the Company has not yet established its health and dental insurance. Therefore,
you should exercise your COBRA rights and elect to continue your current health and dental insurance.
The Company will reimburse you for your COBRA premiums.

     3. Stock Options. Subject to the approval of the Board of Directors of CytoTherapeutics, you will be granted a time-vesting option for 20,000 shares of CytoTherapeutics stock at a price equal to the
fair market value at the time of your start date. The vesting of these shares will commence after the
first twelve months of your employment. At the end of twelve months, 12/48 will vest and 1/48 will vest monthly thereafter. In addition, and subject to the approval of the SCI Research Committee, you will be granted an additional performance-based stock option for 40,000 shares at a price equal to the

 

 

fair market value at the time of your start date based upon achievement of these milestones: 1) establishing a fully operational StemCells unit (13,333 shares vest); 2) discovery and patent filing describing the composition of a human stem cell (13,333 shares vest); 3) discovery and patent filing describing the composition of a mammalian stem cell (13,333 shares vest).

     4. At Will Employment. You should be aware that your employment with the Company is for no specified period and constitutes “at-will” employment. As a result, you are free to terminate your employment at any time, for any reason or for no reason. Similarly, the Company is free to terminate
your employment at any time, for any reason or for no reason. In the event of termination of your employment, you will not be entitled to any payments, benefits, damages or compensation other than as may otherwise be available in accordance with Section 5.

     5. Severance Agreement. While the Company is free to terminate your employment at any time, for any reason or for no reason, in the event of termination of your employment by the Company without Justifiable Cause (as defined below) during the first year of your employment, you will be entitled to your monthly base salary paid each month for the lesser of twelve (12) months or the number of months until
you have accepted an offer of employment elsewhere. In the event of termination of your employment by the Company without Justifiable Cause during the second year of your employment, you will be entitled to your monthly base salary paid each month for the lesser of six (6) months or the number of months until you have accepted an offer of employment elsewhere. In the event that you terminate your employment with the Company, or the Company terminates your employment for Justifiable Cause,
or the Company terminates your employment for any reason or no reason after the second
year of your employment, you will not be entitled to any payments, benefits, damages,
awards or compensation other than as may be available in accordance with the Company’s
established plans and policies at the time of termination. The “Justifiable Cause”
shall include the occurrence of any of the following events: (I) the conviction of,
plea or nolo contendere in, a felony or a crime involving moral turpitude,
(ii) the commission of an intentional act of personal dishonesty or
breach of fiduciary duty involving personal profit in connection with the
Company, (iii) the commission of an act, or failure to act, which the
Board of Directors of the Company shall reasonably have found to have involved gross
misconduct or gross negligence in the conduct of your duties, and (iv) alcoholism,
drug dependency, or habitual absenteeism which interferes with the performance of your duties.

     6. Proprietary Information Agreement. As a condition of accepting this offer of employment, you will be required to complete, sign and return the Company’s standard form of Employee Proprietary Information Agreement.

     7. Immigration Laws. For
the purposes of federal immigration laws, you will be required to provide to the Company
documentary evidence of your identity and eligibility for employment in the United States.
The Company will assist you, if needed, to obtain the appropriate documentation.
Such documentation must be provided within 3 (three) business days of
the effective date of your
employment, or your employment relationship with the Company may be terminated.

     8. Physical Exam. This offer of employment is contingent upon successful completion of a medical exam which will be paid for by the Company. You will begin employment only after

 

 

successfully passing a medical exam. The results are generally available within 72 hours and you will be notified of the results.

     9. General. This offer letter, the Employee Proprietary Information Agreement and the Employee Stock Option Agreement, when signed by you, sets forth the terms of your employment with the Company and supersedes any and all prior representations and agreements, whether written or oral. This agreement can only be amended in a written document signed by you and an officer of the Company. This agreement will be
governed by California law. Upon acceptance of this offer we will request from the Board of Directors that you be provided a severance package and accelerated vesting of options in the event of a Change of Control consistent with current Company policies applicable to Officers.

We look forward to you joining the Company. If the foregoing terms are agreeable, please indicate your acceptance by signing both enclosed copies of this letter in the space below, keeping one copy for your files and returning one copy to me. I will have your Employee Proprietary Information and Employee Stock Option Agreements sent separately.

Sincerely,

/s/ Richard M. Rose

Richard M. Rose, M.D.

President and CEO

AGREED AND ACCEPTED:

	 	 	 
	/s/ Ann Tsukamoto
 

Ann Tsukamoto, Ph.D.exv10w28

Exhibit 10.28

	 	 	 
	

	 	MEMORANDUM

	 	     	 
	TO:

	 	Dr. Ann Tsukamoto, Vice President of Scientific Operations
	 	 	 
	FROM:

	 	Marie Berticevich, Manager of Human Resources & Administration
	 	 	 
	SUBJECT:

	 	Amendment to Offer Letter
	 	 	 
	DATE:

	 	July 17, 2000

Following is an amendment to your offer of employment dated February 2, 1998:

Either you or StemCells may terminate your employment relationship at any time with or
without cause. However, if your employment with StemCells is involuntarily terminated
without cause at any time, including a Change of Control, you will be provided with salary
continuation and benefits continuation under COBRA from the date of termination until the
date twelve (12) months after the effective date of the termination equal to the salary which
you were receiving at the time of such termination; payments shall be paid in accordance
with the Company’s standard payroll practices. In addition, any Change of Control or
involuntary termination as stated, will result in the accelerated vesting of your 1992 Equity
Incentive Plan Time-Based options to acquire 100% of such shares.

As used in this agreement, termination for cause shall mean (I) gross negligence or willful
misconduct in the performance of the Employee’s duties to the Company where such gross
negligence or willful misconduct has resulted or is likely to result in substantial and material
damage to the company; (II) repeated unexplained or justified absence from the Company;
(III) a material and willful violation of any federal or state law; (lV) commission of any act of
fraud with respect to the Company; or (V) conviction of a felony or a crime involuntary
moral turpitude causing material harm to the standing and reputation of the Company.

As used in this agreement, change of control shall mean (I) a merger or consolidation of the
Company which results in the voting securities of the Company representing less that fifty
percent (50%) of the total voting securities of the Company or such surviving entity
outstanding immediately after such a merger, (II) liquidation or sale of substantially all of the
Company’s assets.

STEMCELLS, INC.

	 	 	 	 	 
	By: 

Title:

	 	/s/ George Dunbar
 

Acting President & CEO
	 	 
	 
	 	 	 	 
	Dated: July 17, 2000	 	 

				
	EMPLOYEE:	 	/s/ Ann Tsukamoto
 
	 

Dated: September 5, 2000

525 Del Rey Avenue, Suite C • Sunnyvale, CA

94085 408.731.8670 • Fax 408.731.8674

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]